NCT00203268View on ClinicalTrials.gov

A Study Examining the Use of a Migraine Medicine in the Treatment of Two Migraine Attacks in Patients Who Have Increased Skin Sensitivity

NACompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

March 31, 2005

Study Completion Date

March 31, 2005

Conditions
Migraine
Interventions
DRUG

dihydroergotamine mesylate

1.0 mg. intramuscularly

Trial Locations (1)

19107

Jefferson Headache Center, Philadelphia

All Listed Sponsors
collaborator

Bausch Health Americas, Inc.

INDUSTRY

lead

Thomas Jefferson University

OTHER

NCT00203268 - A Study Examining the Use of a Migraine Medicine in the Treatment of Two Migraine Attacks in Patients Who Have Increased Skin Sensitivity | Biotech Hunter | Biotech Hunter